Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A. Yardley, M.D.
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nea Baptist Clinic
Jonesboro, Arkansas, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Baptist Hospital East
Louisville, Kentucky, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Hematology Oncology Clinic, Llp
Baton Rouge, Louisiana, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- National Capital Clinical Research Consortium
Bethesda, Maryland, United States
- Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, United States
- Nebraska Methodist Cancer Center
Omaha, Nebraska, United States
- Portsmouth Regional Hospital
Portsmouth, New Hampshire, United States
- Oncology Hematology Care, Inc
Cincinnati, Ohio, United States
- Berks Hematology Oncology Associates
West Reading, Pennsylvania, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- the Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
- Peninsula Cancer Institute
Newport News, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 31 Jul 2013
- Completion
- 31 Oct 2014
- Last update posted
- 3 May 2022
- Registered enrollment
- 78
- Registry id
- NCT01033032
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.